nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—HTR2C—metabolic syndrome X	0.832	1	CbGaD
Cyproheptadine—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.0104	0.173	CbGeAlD
Cyproheptadine—HTR2A—arteriole—metabolic syndrome X	0.00976	0.163	CbGeAlD
Cyproheptadine—SLC6A2—autonomic nervous system—metabolic syndrome X	0.00696	0.116	CbGeAlD
Cyproheptadine—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00622	0.104	CbGeAlD
Cyproheptadine—HTR2A—autonomic nervous system—metabolic syndrome X	0.00418	0.0699	CbGeAlD
Cyproheptadine—UGT1A3—liver—metabolic syndrome X	0.00301	0.0504	CbGeAlD
Cyproheptadine—HTR2A—artery—metabolic syndrome X	0.00237	0.0396	CbGeAlD
Cyproheptadine—HTR2A—endothelium—metabolic syndrome X	0.002	0.0335	CbGeAlD
Cyproheptadine—HTR2A—blood vessel—metabolic syndrome X	0.00185	0.0309	CbGeAlD
Cyproheptadine—Clozapine—FMO3—metabolic syndrome X	0.00184	0.334	CrCbGaD
Cyproheptadine—Chest discomfort—Metformin—metabolic syndrome X	0.00175	0.0872	CcSEcCtD
Cyproheptadine—CHRM2—cardiovascular system—metabolic syndrome X	0.0017	0.0285	CbGeAlD
Cyproheptadine—CHRM1—cardiovascular system—metabolic syndrome X	0.00155	0.0259	CbGeAlD
Cyproheptadine—HTR2B—cardiovascular system—metabolic syndrome X	0.00154	0.0258	CbGeAlD
Cyproheptadine—HTR1A—cardiovascular system—metabolic syndrome X	0.00138	0.0231	CbGeAlD
Cyproheptadine—HTR2B—adipose tissue—metabolic syndrome X	0.00136	0.0227	CbGeAlD
Cyproheptadine—CHRM3—kidney—metabolic syndrome X	0.00136	0.0227	CbGeAlD
Cyproheptadine—Nasal congestion—Metformin—metabolic syndrome X	0.00124	0.0615	CcSEcCtD
Cyproheptadine—CHRM3—adipose tissue—metabolic syndrome X	0.00122	0.0205	CbGeAlD
Cyproheptadine—Metixene—HTR2C—metabolic syndrome X	0.000998	0.182	CrCbGaD
Cyproheptadine—Sweating increased—Metformin—metabolic syndrome X	0.000948	0.0472	CcSEcCtD
Cyproheptadine—HRH1—adipose tissue—metabolic syndrome X	0.00087	0.0145	CbGeAlD
Cyproheptadine—Drowsiness—Metformin—metabolic syndrome X	0.000868	0.0432	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000851	0.0423	CcSEcCtD
Cyproheptadine—HTR2A—cardiovascular system—metabolic syndrome X	0.000824	0.0138	CbGeAlD
Cyproheptadine—HTR2A—kidney—metabolic syndrome X	0.000806	0.0135	CbGeAlD
Cyproheptadine—Hepatitis—Metformin—metabolic syndrome X	0.000779	0.0388	CcSEcCtD
Cyproheptadine—Chills—Metformin—metabolic syndrome X	0.000699	0.0348	CcSEcCtD
Cyproheptadine—Vision blurred—Metformin—metabolic syndrome X	0.000639	0.0318	CcSEcCtD
Cyproheptadine—Tremor—Metformin—metabolic syndrome X	0.000636	0.0316	CcSEcCtD
Cyproheptadine—Syncope—Metformin—metabolic syndrome X	0.000608	0.0303	CcSEcCtD
Cyproheptadine—Palpitations—Metformin—metabolic syndrome X	0.000599	0.0298	CcSEcCtD
Cyproheptadine—Loss of consciousness—Metformin—metabolic syndrome X	0.000596	0.0296	CcSEcCtD
Cyproheptadine—Mianserin—HTR2C—metabolic syndrome X	0.000573	0.104	CrCbGaD
Cyproheptadine—Oedema—Metformin—metabolic syndrome X	0.000554	0.0275	CcSEcCtD
Cyproheptadine—Shock—Metformin—metabolic syndrome X	0.000545	0.0271	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Metformin—metabolic syndrome X	0.000542	0.027	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Metformin—metabolic syndrome X	0.000535	0.0266	CcSEcCtD
Cyproheptadine—Anorexia—Metformin—metabolic syndrome X	0.000528	0.0262	CcSEcCtD
Cyproheptadine—Hypotension—Metformin—metabolic syndrome X	0.000517	0.0257	CcSEcCtD
Cyproheptadine—Nortriptyline—HTR2C—metabolic syndrome X	0.000513	0.0933	CrCbGaD
Cyproheptadine—HTR2A—liver—metabolic syndrome X	0.00051	0.00852	CbGeAlD
Cyproheptadine—Paraesthesia—Metformin—metabolic syndrome X	0.000497	0.0247	CcSEcCtD
Cyproheptadine—Somnolence—Metformin—metabolic syndrome X	0.000492	0.0245	CcSEcCtD
Cyproheptadine—Dyspepsia—Metformin—metabolic syndrome X	0.000487	0.0242	CcSEcCtD
Cyproheptadine—Decreased appetite—Metformin—metabolic syndrome X	0.000481	0.0239	CcSEcCtD
Cyproheptadine—Fatigue—Metformin—metabolic syndrome X	0.000477	0.0237	CcSEcCtD
Cyproheptadine—Constipation—Metformin—metabolic syndrome X	0.000473	0.0235	CcSEcCtD
Cyproheptadine—Feeling abnormal—Metformin—metabolic syndrome X	0.000456	0.0227	CcSEcCtD
Cyproheptadine—Loxapine—HTR2C—metabolic syndrome X	0.000456	0.0829	CrCbGaD
Cyproheptadine—Urticaria—Metformin—metabolic syndrome X	0.00044	0.0219	CcSEcCtD
Cyproheptadine—Asthenia—Metformin—metabolic syndrome X	0.000397	0.0198	CcSEcCtD
Cyproheptadine—Clozapine—HTR2C—metabolic syndrome X	0.000383	0.0696	CrCbGaD
Cyproheptadine—Diarrhoea—Metformin—metabolic syndrome X	0.000379	0.0188	CcSEcCtD
Cyproheptadine—Dizziness—Metformin—metabolic syndrome X	0.000366	0.0182	CcSEcCtD
Cyproheptadine—Amitriptyline—HTR2C—metabolic syndrome X	0.000356	0.0647	CrCbGaD
Cyproheptadine—Vomiting—Metformin—metabolic syndrome X	0.000352	0.0175	CcSEcCtD
Cyproheptadine—Rash—Metformin—metabolic syndrome X	0.000349	0.0174	CcSEcCtD
Cyproheptadine—Dermatitis—Metformin—metabolic syndrome X	0.000349	0.0173	CcSEcCtD
Cyproheptadine—Headache—Metformin—metabolic syndrome X	0.000347	0.0172	CcSEcCtD
Cyproheptadine—Nausea—Metformin—metabolic syndrome X	0.000329	0.0164	CcSEcCtD
Cyproheptadine—Nortriptyline—ALB—metabolic syndrome X	0.000223	0.0407	CrCbGaD
Cyproheptadine—Amitriptyline—ALB—metabolic syndrome X	0.000155	0.0282	CrCbGaD
Cyproheptadine—HTR2B—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.45e-05	0.000298	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AGT—metabolic syndrome X	2.44e-05	0.000296	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CYBA—metabolic syndrome X	2.44e-05	0.000296	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AGT—metabolic syndrome X	2.43e-05	0.000296	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HTR2C—metabolic syndrome X	2.43e-05	0.000295	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AGT—metabolic syndrome X	2.43e-05	0.000295	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AGT—metabolic syndrome X	2.42e-05	0.000294	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—LPL—metabolic syndrome X	2.4e-05	0.000292	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CYBA—metabolic syndrome X	2.4e-05	0.000291	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AGT—metabolic syndrome X	2.4e-05	0.000291	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CYBA—metabolic syndrome X	2.39e-05	0.000291	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—GHRL—metabolic syndrome X	2.39e-05	0.00029	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CYBA—metabolic syndrome X	2.39e-05	0.00029	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CYBA—metabolic syndrome X	2.38e-05	0.000289	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CYBA—metabolic syndrome X	2.35e-05	0.000286	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—GHRL—metabolic syndrome X	2.35e-05	0.000285	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—GHRL—metabolic syndrome X	2.34e-05	0.000285	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—GHRL—metabolic syndrome X	2.33e-05	0.000284	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—GHRL—metabolic syndrome X	2.33e-05	0.000283	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—CCL2—metabolic syndrome X	2.33e-05	0.000283	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—CCL2—metabolic syndrome X	2.31e-05	0.000281	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—GHRL—metabolic syndrome X	2.3e-05	0.00028	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—PTGS2—metabolic syndrome X	2.3e-05	0.000279	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CNR1—metabolic syndrome X	2.26e-05	0.000274	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AGT—metabolic syndrome X	2.25e-05	0.000274	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CNR1—metabolic syndrome X	2.22e-05	0.00027	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CNR1—metabolic syndrome X	2.22e-05	0.00027	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CNR1—metabolic syndrome X	2.21e-05	0.000269	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—APOE—metabolic syndrome X	2.21e-05	0.000268	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—LEP—metabolic syndrome X	2.21e-05	0.000268	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CNR1—metabolic syndrome X	2.2e-05	0.000268	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—APOA1—metabolic syndrome X	2.18e-05	0.000265	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CNR1—metabolic syndrome X	2.18e-05	0.000265	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IGF2—metabolic syndrome X	2.1e-05	0.000256	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IGF2—metabolic syndrome X	2.09e-05	0.000254	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—APOB—metabolic syndrome X	2.09e-05	0.000254	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AGT—metabolic syndrome X	2.06e-05	0.00025	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—APOB—metabolic syndrome X	2.04e-05	0.000248	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—CCL2—metabolic syndrome X	2.04e-05	0.000248	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PLA2G4A—metabolic syndrome X	2.03e-05	0.000247	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—APOB—metabolic syndrome X	2.03e-05	0.000247	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—LEP—metabolic syndrome X	2.02e-05	0.000245	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—APOE—metabolic syndrome X	2.02e-05	0.000245	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—CCL2—metabolic syndrome X	2.01e-05	0.000244	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—CCL2—metabolic syndrome X	2e-05	0.000244	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—CCL2—metabolic syndrome X	2e-05	0.000243	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—LPL—metabolic syndrome X	2e-05	0.000243	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCL5—metabolic syndrome X	1.99e-05	0.000242	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—APOA1—metabolic syndrome X	1.99e-05	0.000242	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—CCL2—metabolic syndrome X	1.99e-05	0.000242	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.99e-05	0.000241	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCL5—metabolic syndrome X	1.98e-05	0.000241	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.98e-05	0.00024	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—CCL2—metabolic syndrome X	1.97e-05	0.00024	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IRS1—metabolic syndrome X	1.97e-05	0.000239	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—LPL—metabolic syndrome X	1.95e-05	0.000237	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—LPL—metabolic syndrome X	1.94e-05	0.000236	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—CD36—metabolic syndrome X	1.9e-05	0.000231	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—INS—metabolic syndrome X	1.89e-05	0.000229	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CCL2—metabolic syndrome X	1.86e-05	0.000226	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IGF2—metabolic syndrome X	1.85e-05	0.000224	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IGF1—metabolic syndrome X	1.82e-05	0.000222	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IGF2—metabolic syndrome X	1.82e-05	0.000221	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IGF2—metabolic syndrome X	1.81e-05	0.00022	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IGF2—metabolic syndrome X	1.81e-05	0.00022	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IGF2—metabolic syndrome X	1.8e-05	0.000219	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IRS1—metabolic syndrome X	1.8e-05	0.000218	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—APOB—metabolic syndrome X	1.79e-05	0.000218	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IGF2—metabolic syndrome X	1.78e-05	0.000217	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PPARA—metabolic syndrome X	1.76e-05	0.000214	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—APOB—metabolic syndrome X	1.76e-05	0.000214	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—APOB—metabolic syndrome X	1.76e-05	0.000214	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—APOB—metabolic syndrome X	1.75e-05	0.000213	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCL5—metabolic syndrome X	1.75e-05	0.000213	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—APOB—metabolic syndrome X	1.75e-05	0.000213	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.74e-05	0.000212	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—SERPINE1—metabolic syndrome X	1.73e-05	0.000211	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—APOB—metabolic syndrome X	1.73e-05	0.00021	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCL5—metabolic syndrome X	1.72e-05	0.000209	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—INS—metabolic syndrome X	1.72e-05	0.000209	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCL5—metabolic syndrome X	1.72e-05	0.000209	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.72e-05	0.000209	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCL5—metabolic syndrome X	1.71e-05	0.000208	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.71e-05	0.000208	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—LPL—metabolic syndrome X	1.71e-05	0.000208	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AGT—metabolic syndrome X	1.71e-05	0.000208	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCL5—metabolic syndrome X	1.71e-05	0.000208	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.71e-05	0.000207	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.7e-05	0.000207	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CCL2—metabolic syndrome X	1.69e-05	0.000206	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCL5—metabolic syndrome X	1.69e-05	0.000206	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.69e-05	0.000205	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—LPL—metabolic syndrome X	1.68e-05	0.000205	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—LPL—metabolic syndrome X	1.68e-05	0.000204	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—LPL—metabolic syndrome X	1.68e-05	0.000204	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—APOE—metabolic syndrome X	1.67e-05	0.000203	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—LPL—metabolic syndrome X	1.67e-05	0.000203	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AGT—metabolic syndrome X	1.67e-05	0.000203	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IGF1—metabolic syndrome X	1.67e-05	0.000202	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AGT—metabolic syndrome X	1.66e-05	0.000202	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—APOA1—metabolic syndrome X	1.66e-05	0.000201	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—NOS3—metabolic syndrome X	1.65e-05	0.000201	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—LPL—metabolic syndrome X	1.65e-05	0.000201	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—APOE—metabolic syndrome X	1.63e-05	0.000199	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—LEP—metabolic syndrome X	1.63e-05	0.000199	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—APOE—metabolic syndrome X	1.63e-05	0.000198	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—LEP—metabolic syndrome X	1.63e-05	0.000198	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—APOA1—metabolic syndrome X	1.62e-05	0.000196	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—APOA1—metabolic syndrome X	1.61e-05	0.000195	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.58e-05	0.000192	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—NOS3—metabolic syndrome X	1.51e-05	0.000183	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AGT—metabolic syndrome X	1.46e-05	0.000178	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PPARG—metabolic syndrome X	1.46e-05	0.000177	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IRS1—metabolic syndrome X	1.46e-05	0.000177	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IRS1—metabolic syndrome X	1.45e-05	0.000176	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AGT—metabolic syndrome X	1.44e-05	0.000175	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AGT—metabolic syndrome X	1.44e-05	0.000175	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—APOE—metabolic syndrome X	1.44e-05	0.000174	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—LEP—metabolic syndrome X	1.44e-05	0.000174	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AGT—metabolic syndrome X	1.43e-05	0.000174	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—INS—metabolic syndrome X	1.43e-05	0.000174	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AGT—metabolic syndrome X	1.43e-05	0.000174	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—APOA1—metabolic syndrome X	1.42e-05	0.000172	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—AKT1—metabolic syndrome X	1.42e-05	0.000172	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AGT—metabolic syndrome X	1.41e-05	0.000172	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	1.41e-05	0.000172	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—LEP—metabolic syndrome X	1.41e-05	0.000172	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—LEP—metabolic syndrome X	1.41e-05	0.000171	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—APOE—metabolic syndrome X	1.41e-05	0.000171	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—APOE—metabolic syndrome X	1.4e-05	0.000171	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—LEP—metabolic syndrome X	1.4e-05	0.000171	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—APOE—metabolic syndrome X	1.4e-05	0.00017	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—LEP—metabolic syndrome X	1.4e-05	0.00017	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—INS—metabolic syndrome X	1.4e-05	0.00017	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	1.4e-05	0.00017	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—IL6—metabolic syndrome X	1.4e-05	0.00017	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—APOA1—metabolic syndrome X	1.39e-05	0.000169	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.39e-05	0.000169	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—APOA1—metabolic syndrome X	1.39e-05	0.000169	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—LEP—metabolic syndrome X	1.39e-05	0.000168	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—APOE—metabolic syndrome X	1.39e-05	0.000168	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—APOA1—metabolic syndrome X	1.38e-05	0.000168	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	1.37e-05	0.000167	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—APOA1—metabolic syndrome X	1.37e-05	0.000167	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.37e-05	0.000166	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	1.35e-05	0.000164	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.34e-05	0.000163	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—ALB—metabolic syndrome X	1.31e-05	0.000159	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.29e-05	0.000157	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—AKT1—metabolic syndrome X	1.29e-05	0.000156	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.28e-05	0.000156	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	1.28e-05	0.000156	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.28e-05	0.000155	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL6—metabolic syndrome X	1.27e-05	0.000155	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	1.26e-05	0.000153	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	1.26e-05	0.000153	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—NOS3—metabolic syndrome X	1.25e-05	0.000152	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IRS1—metabolic syndrome X	1.25e-05	0.000152	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IRS1—metabolic syndrome X	1.25e-05	0.000152	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IRS1—metabolic syndrome X	1.24e-05	0.00015	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—INS—metabolic syndrome X	1.23e-05	0.000149	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	1.22e-05	0.000149	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	1.22e-05	0.000148	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—INS—metabolic syndrome X	1.21e-05	0.000147	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	1.21e-05	0.000147	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—INS—metabolic syndrome X	1.2e-05	0.000146	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—INS—metabolic syndrome X	1.2e-05	0.000146	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—INS—metabolic syndrome X	1.2e-05	0.000145	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	1.19e-05	0.000144	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	1.19e-05	0.000144	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—INS—metabolic syndrome X	1.18e-05	0.000144	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	1.18e-05	0.000144	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	1.18e-05	0.000143	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCL2—metabolic syndrome X	1.18e-05	0.000143	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—AKT1—metabolic syndrome X	1.17e-05	0.000143	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	1.17e-05	0.000142	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	1.17e-05	0.000142	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	1.16e-05	0.000141	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	1.16e-05	0.000141	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IGF1—metabolic syndrome X	1.16e-05	0.000141	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—AKT1—metabolic syndrome X	1.15e-05	0.00014	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTGS2—metabolic syndrome X	1.15e-05	0.000139	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	1.15e-05	0.000139	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.13e-05	0.000137	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.11e-05	0.000135	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.11e-05	0.000134	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.1e-05	0.000134	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SERPINE1—metabolic syndrome X	1.1e-05	0.000133	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TGFB1—metabolic syndrome X	1.09e-05	0.000133	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.09e-05	0.000132	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	1.08e-05	0.000131	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	1.06e-05	0.000129	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	1.06e-05	0.000128	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	1.05e-05	0.000128	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	1.05e-05	0.000127	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NOS3—metabolic syndrome X	1.05e-05	0.000127	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	1.04e-05	0.000127	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	1.04e-05	0.000126	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	1.03e-05	0.000125	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	1.03e-05	0.000125	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TGFB1—metabolic syndrome X	9.98e-06	0.000121	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	9.53e-06	0.000116	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	9.48e-06	0.000115	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	9.21e-06	0.000112	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	9.07e-06	0.00011	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	9.06e-06	0.00011	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	9.04e-06	0.00011	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	9.02e-06	0.00011	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AKT1—metabolic syndrome X	8.99e-06	0.000109	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	8.92e-06	0.000108	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	8.9e-06	0.000108	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	8.9e-06	0.000108	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	8.87e-06	0.000108	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6—metabolic syndrome X	8.85e-06	0.000107	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	8.76e-06	0.000106	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	8.37e-06	0.000102	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6—metabolic syndrome X	8.24e-06	0.0001	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	8.23e-06	0.0001	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	8.21e-06	9.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	8.19e-06	9.95e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AKT1—metabolic syndrome X	8.16e-06	9.92e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	8.1e-06	9.84e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	8.08e-06	9.82e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	8.06e-06	9.79e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKT1—metabolic syndrome X	7.6e-06	9.24e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6—metabolic syndrome X	7.52e-06	9.14e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	7.11e-06	8.64e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.99e-06	8.5e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	6.98e-06	8.48e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	6.96e-06	8.45e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKT1—metabolic syndrome X	6.94e-06	8.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TGFB1—metabolic syndrome X	6.94e-06	8.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	6.87e-06	8.35e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	6.1e-06	7.41e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	6.07e-06	7.38e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AKT1—metabolic syndrome X	5.77e-06	7.01e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	5.63e-06	6.84e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	5.6e-06	6.8e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6—metabolic syndrome X	5.36e-06	6.51e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	5.27e-06	6.4e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6—metabolic syndrome X	5.26e-06	6.39e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	5.24e-06	6.37e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6—metabolic syndrome X	5.23e-06	6.35e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	5.18e-06	6.29e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	4.94e-06	6e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	4.86e-06	5.91e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	4.85e-06	5.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	4.84e-06	5.88e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT1—metabolic syndrome X	4.82e-06	5.86e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	4.77e-06	5.8e-05	CbGpPWpGaD
